COVID-19-related business has helped to lift the fortunes of leading China drug entrepreneurs. : Zhong Huijuan, one of the world’s wealthiest women, led the way on new list of China’s richest people in healthcare published in the latest issue of Forbes China, the Chinese-language edition of Forbes. Zhong, 59, chairs Hansoh Pharmaceutical Group, a Hong Kong-listed supplier of cancer and diabetes treatments. Zhong had an estimated fortune worth $19.8 billion as of July 17, the pricing date for the new list. That compares with her fortune of $14.6 billion on the 2020 Forbes Billionaires List priced on March 18.